Bayer beats rivals to Japanese market with cancer drug. Bayer AG's (BAYRY.PK) treatment for advanced kidney cancer, Nexavar, has been approved for use in Japan.
The drug, which is already approved in the U.S. and Europe, is codeveloped by Onyx Pharmaceuticals (ONXX).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment